How Does the Patient Benefit from Clinical PET?


Clinical molecular imaging by use of PET and PET/CT is increasingly important in routine oncological practice worldwide. A vast majority of clinical PET investigations are performed with [(18)F]-fluorodeoxyglucose (FDG), but there is a growing interest in novel molecular probes among scientists and clinicians. Beyond FDG, a small number of different tracers… (More)
DOI: 10.7150/thno.3794

6 Figures and Tables


  • Presentations referencing similar topics